NCT03074773

Brief Summary

Anesthetic management for surgery of aortic coarctation needs special care due to severe pain during lateral thoracotomy incision, the intraoperative hemodynamic instability related to skin incision at lateral thoracotomy, clamping and declamping of the aorta, needs of large doses of analgesia perioperative, needs of vasodilators. Also, postoperative care of the patients after repair is very important issue. The investigators will compare the effect of para-vertebral block with bupivacaine alone or with dexamethasone on Intra and postoperative analgesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Oct 2016

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 30, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 24, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 9, 2017

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2017

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2017

Completed
Last Updated

July 19, 2017

Status Verified

July 1, 2017

Enrollment Period

5 months

First QC Date

February 24, 2017

Last Update Submit

July 18, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • Intraoperative fentanyl needs

    total fentanyl consumption intraoperatively

    3hours

  • postoperative analgesic requirements

    total narcotic consumption

    24hours

Secondary Outcomes (2)

  • the first time the analgesic required

    24 hours

  • extubation time

    24 hours

Study Arms (2)

paravertebral block with bupivacaine

ACTIVE COMPARATOR

this group will receive 0.5mg/kg bupivacaine 0.25% diluted with isotonic saline (total volume 15ml) paravertebral block ultrasound guided pre-emptively

Device: ultrasoundProcedure: paravertebral blockDrug: BupivacaineOther: isotonic saline

paravertebral block with bupivacaine and dexamethasone

ACTIVE COMPARATOR

this group will receive 0.5mg/kg bupivacaine 0.25% mixed to 0.1 mg/kg dexamethasone diluted with isotonic saline (total volume 15ml) paravertebral block ultrasound guided pre-emptively

Drug: DexamethasoneDevice: ultrasoundProcedure: paravertebral blockDrug: Bupivacaine

Interventions

Dexamethasone is commonly used in the perioperative period to reduce postoperative nausea and vomiting. Additionally, it has been reported to have analgesic effects. The analgesic effect of epidural or perineural dexamethasone administration is not clear. Dexamethasone might have a local anesthetic effect on nerve by direct membrane action

Also known as: decadron
paravertebral block with bupivacaine and dexamethasone

The growth of ultrasound technology and, with it, our ability to visualize the pleura and other structures in and around the paravertebral space has fueled a tremendous increased interest in performing thoracic paravertebral blocks. These blocks may be used for acute pain control, as an adjunct to general anesthesia for peri-operative pain control and, in some practices, as the primary anesthetic

paravertebral block with bupivacaineparavertebral block with bupivacaine and dexamethasone

paravertebral block is an effective analgesic technique used in various types of surgery, trauma and chronic pain. it decreases postoperative pain and reduces opioid consumption which in turns improve postoperative pulmonary function hoping for early extubation.

paravertebral block with bupivacaineparavertebral block with bupivacaine and dexamethasone

it is an amino amide local anesthetic drug

Also known as: marcain
paravertebral block with bupivacaineparavertebral block with bupivacaine and dexamethasone

sterile sodium chloride solution at physiological concentration (0.87%); used as diluting agent when added to local anesthetic drug

Also known as: normal saline
paravertebral block with bupivacaine

Eligibility Criteria

Age4 Months - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • m-6 years males and females scheduled for surgery for coarctation of the aorta

You may not qualify if:

  • patients with associated other cardiac anomalies (e.g. VSD), patients with airway abnormality, patients with heart failure, patients with endocrine disorders, patients with history of convulsions, neurological disorder, hepatic, renal and neuromuscular diseases, coagulopathy, history of hyperthermia, infection at site of the block and family history of hypersensitivity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Amany Hassan Saleh

Cairo, 02, Egypt

Location

Related Publications (1)

  • Saleh AH, Hassan PF, Elayashy M, Hamza HM, Abdelhamid MH, Madkour MA, Tawadros PZ, Omar H, Kamel MM, Zayed M, Helmy M. Role of dexamethasone in the para-vertebral block for pediatric patients undergoing aortic coarctation repair. randomized, double-blinded controlled study. BMC Anesthesiol. 2018 Nov 30;18(1):178. doi: 10.1186/s12871-018-0637-y.

MeSH Terms

Conditions

Aortic Coarctation

Interventions

DexamethasoneCalcium DobesilateUltrasonographyBupivacaineSodium ChlorideSaline Solution

Condition Hierarchy (Ancestors)

Heart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

PregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, FluorinatedBenzenesulfonatesBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsArylsulfonatesArylsulfonic AcidsSulfonic AcidsSulfur AcidsSulfur CompoundsDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisAnilidesAmidesAniline CompoundsAminesChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium CompoundsCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • kasr alaini hospital

    Cairo University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecture of anethesia, Cairo university

Study Record Dates

First Submitted

February 24, 2017

First Posted

March 9, 2017

Study Start

October 30, 2016

Primary Completion

March 30, 2017

Study Completion

April 15, 2017

Last Updated

July 19, 2017

Record last verified: 2017-07

Data Sharing

IPD Sharing
Will not share

Locations